Renewal of Schrodinger Small Molecule Drug Discovery Suite software license
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
- Original Published Date: Jan 18, 2022 04:47 pm EST
- Original Date Offers Due: Jan 24, 2022 11:00 am EST
- Inactive Policy: 15 days after date offers due
- Original Inactive Date: Feb 08, 2022
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: 7A21 - IT AND TELECOM - BUSINESS APPLICATION SOFTWARE (PERPETUAL LICENSE SOFTWARE)
- NAICS Code:
- 511210 - Software Publishers
- Place of Performance: Rockville , MD 20850USA
Description
The National Institute on Drug Abuse (NIDA), NIDA Office of Acquisition – NCATS Section, on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Schrodinger, L.L.C., 101 SW Main Street, Ste 1300, Portland, OR 97204, for renewal of licenses for the Small Molecule Drug Discovery Suite software. The anticipated award date is January 26, 2022. See the attached combined synopsis/solicitation for full details and requirements.
Attachments/Links
Contact Information
Contracting Office Address
- c/o 3WFN MSC 6012 301 N Stonestreet Ave
- Bethesda , MD 20892
- USA
Primary Point of Contact
- Stuart Kern
- stuart.kern@nih.gov
Secondary Point of Contact
History
- Feb 08, 2022 11:55 pm ESTCombined Synopsis/Solicitation (Original)